Using PET/CT with 18F-fluorodeoxyglucose–labeled leukocytes is a noninvasive and reliable method to help diagnose acute pancreatitis.
PET plus CT with 18F-fluorodeoxyglucose (FDG)–labeled leukocytes can be used to diagnose infection in pancreatic or peripancreatic fluid collections in patients with acute pancreatitis (AP), according to a study published in The Journal of Nuclear Medicine.
Researchers from India undertook a study to determine if using PET/CT with 18F-FDG–labeled leukocytes for early detection of AP could affect the choice of treatment and clinical outcomes of patients who had acute pancreatitis.
The study included 28 men and 13 women, mean age 41. All were diagnosed with AP and had radiologic evidence of fluid collection in or around the pancreas. The radiotracer 18F-FDG was added to leukocytes that had been separated from the patients’ venous blood, and then was intravenously administered back to the patient. The patients then underwent PET/CT imaging two hours after receiving the radiotracer. Final diagnosis of AP was based on microbiologic culture of fluid aspirated from the collection.
Results:
There was an increased tracer uptake in the fluid collection in 12 of 41 patients. Ten patients had culture-proven infection and underwent percutaneous drainage. Aspiration was unsuccessful in two. “The scan results were negative for infection in 29 patients; 25 had fluid culture results that were negative for infection, and aspiration was unsuccessful in four,” the authors wrote. “The sensitivity, specificity, and accuracy of the scan were all 100 percent in 35 patients for whom fluid culture reports were available.”
The authors concluded that PET/CT with 18F-FDG–labeled leukocytes is both a noninvasive and reliable method for the diagnosis of infection in pancreatic or peripancreatic fluid collections in patients with AP.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.